太阳娱乐娱城账号登录|首頁_欢迎您!!

关于太阳娛乐城手机游戏 About
公司简介

image.png

太阳娱乐娱城账号登录(简称“太阳娛乐城官网研新”)于2012年,在上海张江药谷成立。公司现有上海、南京两个研发中心,成都临床子公司,建立了一支高效的研发团队。现有员工约200人,拥有4000多万元的专业研发设备。太阳娛乐城手机游戏综合研发平台主要针对小分子创新药、改良型创新药、高难度药物制剂、DMF、MAH等,致力于为全球医药企业提供极具市场竞争力的药物品种,着力打造国际化、前沿化的医药研发和创新平台。

Shanghai Bocimed Pharmaceutical Co., Ltd. (Bocimed) was established in Shanghai Zhangjiang Pharma Valley in 2012. Having two internal R&D centers settled in Shanghai and Nanjing, and a subsidiary clinical company in Chengdu, Bocimed now established an efficient R&D team with about 200 staffs and possesses specialized R&D equipments worth more 40 million RMB. Our comprehensive R&D platform mainly focuses upon small molecule innovative drugs, modified innovative drugs, highly difficult pharmaceutical preparations, DMF&MAH and clinical research, committing to provide global pharmaceutical companies with extremely competitive drug and create international and frontier pharmaceutical R&D and innovative platform.


公司拥有100多项药物开发技术,产品聚焦在肿瘤、心血管、免疫、神经和精神等多个治疗领域。公司拥有完善的内部知识产权保障制度,现有已授权的发明专利16项,在审批中的发明专利47项。

Bocimed has more than 100 product development technologies, focusing on various therapeutic areas including oncology, cardiovascular science, immunology, neurological and mental health. With well-established internal intellectual property system,we have 16 authorized and 47 pending approval patents up to now.

1111111.jpg


COPYRIGHT 2015 太阳娱乐娱城账号登录 沪ICP备12000924号-4 本公司保留一切版权 | 条款及细 上海浦东新区松涛路647弄1号楼

沪公网安备 31011502005223号